Key result
Bivalirudin was successfully used for anticoagulation during cardiopulmonary bypass in a small child with heparin-induced thrombocytopenia using novel techniques.
Case Report (n=1)
Bivalirudin can be successfully used as an alternative to heparin for anticoagulation during cardiopulmonary bypass in children with heparin-induced thrombocytopenia.
No takes yet. Share an insight, caveat, or question.
May support bivalirudin in rare pediatric HIT cases during CPB; hypothesis-generating, larger studies needed before adoption.
Dragomer et al. (2011) conducted a case report in Heparin-induced thrombocytopenia (HIT) requiring cardiopulmonary bypass (n=1). Bivalirudin was evaluated on Successful anticoagulation during cardiopulmonary bypass. Bivalirudin was successfully used for anticoagulation during cardiopulmonary bypass in a small child with heparin-induced thrombocytopenia using novel techniques.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: